ELM STREET VENTURES
ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale University and other research institutions in the region (from New York City through Southern New England). With experienced management and access to local, professionally managed venture capital, Elm Street Ventures can help scientists build significant technology companies from the seed and early stage. Our partners include successful serial entrepreneurs and... experienced corporate managers, who may serve as the interim CEOs or operating chairmen of a number of the companies we form. While they expect to be co-founders of companies in some circumstances, ESVC are also interested in hearing from entrepreneurs, scientists, and engineers who have already formed or plan to form new ventures in the life sciences. Attractive markets, solid patent protection and freedom to operate, defensible market position, and a world class management team are elements ultimately critical for success.
ELM STREET VENTURES
Social Links:
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
203-401-4201
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content Google Apps For Business Google Maps
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Draper Dragon
DFJ DragonFund was the joint venture between the internationally recognized venture capital firm Draper Fisher Jurvetson and Draper Dragon.
Polaris Partners
Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-10 | Cybrexa Therapeutics | Elm Street Ventures investment in Series B - Cybrexa Therapeutics | 25 M USD |
| 2021-03-01 | Artizan Biosciences | Elm Street Ventures investment in Series A - Artizan Biosciences | 18.88 M USD |
| 2020-01-29 | P2 Science | Elm Street Ventures investment in Series C - P2 Science | 12 M USD |
| 2020-01-16 | CellFE | Elm Street Ventures investment in Seed Round - CellFE | 4.8 M USD |
| 2020-01-08 | EvolveImmune Therapeutics | Elm Street Ventures investment in Venture Round - EvolveImmune Therapeutics | 17.55 M USD |
| 2019-06-11 | Artizan Biosciences | Elm Street Ventures investment in Series A - Artizan Biosciences | 12 M USD |
| 2019-02-01 | Halda Therapeutics | Elm Street Ventures investment in Series A - Halda Therapeutics | 25 M USD |
| 2018-06-15 | Iconic Therapeutics | Elm Street Ventures investment in Venture Round - Iconic Therapeutics | 4.11 M USD |
| 2017-03-22 | Saphlux | Elm Street Ventures investment in Series A - Saphlux | 5 M USD |
| 2017-03-01 | P2 Science | Elm Street Ventures investment in Series B - P2 Science | 9.55 M USD |